Brasofensine < Bromocriptine < Bromure d'ipratropium

Facettes :

List of bibliographic references indexed by Bromocriptine

Number of relevant bibliographic references: 19.

Ident.	Authors (with country if any)	Title
001773 (2011)	Louis C. S. Tan [Singapour] ; Kenneth K. C. Ng [Singapour] ; Wing-Lok Au [Singapour] ; Raymond K. K. Lee [Singapour] ; Nigel C. K. Tan [Singapour]	Bromocriptine use and myocardial function
001F72 (2010)	Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]	Adverse Drug Reactions to Dopamine Agonists: A Comparative Study in the French Pharmacovigilance Database
002384 (2009)	Tomoyuki Uchiyama [Japon] ; Ryuji Sakakibara [Japon] ; Tatsuya Yamamoto [Japon] ; Takashi Ito [Japon] ; M. Chiharu Yamaguchi [Japon] ; Yusuke Awa [Japon] ; Masashi Yano [Japon] ; Mitsuru Yanagisawa [Japon] ; Makoto Kobayashi [Japon] ; Yoshinori Higuchi [Japon] ; Tomohiko Ichikawa [Japon] ; Tomonori Yamanishi [Japon] ; Takamichi Hattori [Japon] ; Satoshi Kuwabara [Japon]	Comparing bromocriptine effects with levodopa effects on bladder function in Parkinson's disease
002418 (2009)	Louis C. S. Tan [Singapour] ; Kenneth K. C. Ng [Singapour] ; Wing-Lok Au [Singapour] ; Raymond K. K. Lee [Singapour] ; Yiong-Huak Chan [Singapour] ; Nigel C. K. Tan [Singapour]	Bromocriptine use and the risk of valvular heart disease
003125 (2006)	Ji-Youn Kim [Corée du Sud] ; Eun Joo Chung [Corée du Sud] ; Seung Woo Park [Corée du Sud] ; Won Yong Lee [Corée du Sud]	Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists
003623 (2006)	Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France]	The parkinson-control study : A 1-year randomized, double- blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in parkinson's disease
003F71 (2003)	Yoshikuni Mizuno [Japon] ; Nobuo Yanagisawa [Japon] ; Sadako Kuno [Japon] ; Mitsutoshi Yamamoto [Japon] ; Kazuko Hasegawa [Japon] ; Hideki Origasa [Japon] ; Hisayuki Kowa [Japon]	Randomized, double‐blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease
004316 (2002)	Robert A. Hauser [États-Unis] ; Nicholas H. G. Holford [Nouvelle-Zélande]	Quantitative description of loss of clinical benefit following withdrawal of levodopa–carbidopa and bromocriptine in early Parkinson's disease
004626 (2002)		DA agonists: ergot derivatives: Bromocriptine
004759 (2001)	Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France]	Long‐term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease
004933 (2000)	Robert A. Hauser [États-Unis] ; William C. Koller [États-Unis] ; Jean P. Hubble [États-Unis] ; Teresita Malapira [États-Unis] ; Karen Busenbark [États-Unis] ; C. Warren Olanow [États-Unis]	Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson's disease
004945 (2000)	Claudia Ramaker [Pays-Bas] ; Willem Johan T. Van De Beek [Pays-Bas] ; Martijn J. J. Finken [Pays-Bas] ; Bob J. J. Van Hilten [Pays-Bas]	The efficacy and safety of adjunct bromocriptine therapy for levodopa‐induced motor complications: A systematic review
004E53 (1999)		Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated Parkinsonian patients
005034 (1998)	Ronald K. B. Pearce [Royaume-Uni] ; Tara Banerji [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni]	De novo administration of ropinirole and bromocriptine induces less dyskinesia than L‐dopa in the MPTP‐treated marmoset
005114 (1998)	A. D. Korczyn [Israël] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; F. Stocchi [Italie]	Ropinirole versus bromocriptine in the treatment of early Parkinson's disease : A 6-month interim report of a 3-year study
005A47 (1995)	A. M. Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France]	A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists : application to pergolide and bromocriptine
005C60 (1994)	G. Pezzoli [Italie] ; E. Martignoni ; C. Pacchetti ; V. A. Angeleri ; P. Lamberti ; A. Muratorio ; U. Bonuccelli ; M. De Mari ; N. Foschi ; E. Cossutta ; F. Nicoletti ; F. Giammona ; M. Cansei [Italie] ; G. Scarlato [Italie] ; T. Caraceni ; E. Moscarelli	Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study
005E85 (1993)	B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P. J. Bedard	Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors
005E86 (1993)	S. A. Factor [États-Unis] ; W. J. Weiner	Early combination therapy with bromocriptine and levodopa in Parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Bromocriptine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Bromocriptine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Bromocriptine
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024